Bradley Foster & Sargent’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.2M | Buy |
104,695
+846
| +0.8% | +$454K | 0.88% | 32 |
|
2025
Q1 | $43.6M | Buy |
103,849
+15,136
| +17% | +$6.36M | 0.75% | 40 |
|
2024
Q4 | $36.7M | Buy |
88,713
+84,490
| +2,001% | +$34.9M | 0.62% | 46 |
|
2024
Q3 | $2.13M | Buy |
4,223
+3,220
| +321% | +$1.63M | 0.04% | 192 |
|
2024
Q2 | $489K | Sell |
1,003
-12
| -1% | -$5.85K | 0.01% | 356 |
|
2024
Q1 | $548K | Sell |
1,015
-125
| -11% | -$67.5K | 0.01% | 343 |
|
2023
Q4 | $633K | Hold |
1,140
| – | – | 0.01% | 326 |
|
2023
Q3 | $573K | Hold |
1,140
| – | – | 0.01% | 328 |
|
2023
Q2 | $573K | Buy |
1,140
+108
| +10% | +$54.2K | 0.01% | 328 |
|
2023
Q1 | $516K | Buy |
1,032
+59
| +6% | +$29.5K | 0.01% | 326 |
|
2022
Q4 | $397K | Hold |
973
| – | – | 0.01% | 349 |
|
2022
Q3 | $317K | Buy |
+973
| New | +$317K | 0.01% | 361 |
|
2022
Q2 | – | Sell |
-520
| Closed | -$284K | – | 453 |
|
2022
Q1 | $284K | Buy |
520
+115
| +28% | +$62.8K | 0.01% | 409 |
|
2021
Q4 | $267K | Buy |
+405
| New | +$267K | 0.01% | 402 |
|